Skip to main content

Agios Pharmaceuticals, Inc.

AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001439222

In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Agios Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of AGIO: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders2163221+8
Shares61.7M14.2K63.5M+1.82M (+3.0%)
Value$2.05B$473.6K$2.55B+$494.7M (+24.1%)

3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (42)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to AGIO in Q3 2025
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC495,491$19.9M0.04%
SummitTX Capital, L.P.262,977$10.6M0.44%
AXA Investment Managers S.A.177,675$7.13M0.02%
Peregrine Capital Management LLC162,905$6.54M0.20%
Alyeska Investment Group, L.P.146,514$5.88M0.02%
Vestal Point Capital, LP127,000$5.10M0.23%
Ikarian Capital, LLC126,979$5.10M1.16%
Parkman Healthcare Partners LLC100,380$4.03M0.44%
Nantahala Capital Management, LLC100,000$4.01M0.25%
Jump Financial, LLC87,900$3.53M0.04%
Assenagon Asset Management S.A.67,153$2.70M0.00%
Two Sigma Investments, LP59,629$2.39M0.00%
Phocas Financial Corp.46,608$1.87M0.24%
SG Americas Securities, LLC27,650$1.11M0.00%
Winton Group Ltd16,400$658.3K0.02%
Rockefeller Capital Management L.P.16,038$643.8K0.00%
Freestone Grove Partners LP15,424$619.1K0.00%
Two Sigma Advisers, LP13,600$545.9K0.00%
Omers Administration Corp11,200$449.6K0.00%
Cinctive Capital Management LP10,099$405.4K0.02%
Y-Intercept (Hong Kong) Ltd7,932$318.4K0.01%
Voleon Capital Management LP6,682$268.2K0.01%
Point72 Asset Management, L.P.6,507$261.2K0.00%
Cubist Systematic Strategies, LLC6,264$251.4K0.00%
CIBC Bancorp USA Inc.6,021$241.7K0.00%
Fiduciary Trust Co5,454$218.9K0.00%
Northcape Wealth Management, LLC5,240$210.3K0.06%
North Star Asset Management Inc5,000$200.7K0.01%
Quarry LP5,000$200.7K0.05%
Torno Capital, LLC2,500$100.3K0.01%
Quantbot Technologies LP1,976$79.3K0.00%
First Horizon Corp1,124$45.1K0.00%
Advisory Services Network, LLC350$14.0K0.00%
Root Financial Partners, LLC106$4.25K0.00%
Mather Group, LLC.95$3.81K0.00%
Larson Financial Group LLC74$2.97K0.00%
JPL Wealth Management, LLC70$2.81K0.00%
Halbert Hargrove Global Advisors, LLC47$1.89K0.00%
Fifth Third Bancorp30$1.20K0.00%
Quadrant Capital Group LLC16$6430.00%
Wealthspire Advisors, LLC6$2410.00%
Cloud Capital Management, LLC1$00.00%

Sold out (34)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (3)

Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AGIO in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
CIBC World Markets Corp6,959$231.5K
Norges Bank6,756$224.7K
First Horizon Advisors, Inc.523$17.4K